Sandy Spring Bank Vertex Pharmaceuticals Inc Transaction History

Sandy Spring Bank

$2.4 Billion
Q3 2024

A detailed history of Sandy Spring Bank transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sandy Spring Bank holds 1,155 shares of VRTX stock, worth $472,117. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,155

Previous 340 239.71%

Holding current value

$472,117

Previous $159,000 237.74%

% of portfolio

0.02%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$460.0 - $505.78 $374,900 - $412,210	815 Added 239.71%	1,155 $537,000
Q2 2024 Aug 06, 2024	BUY	$392.81 - $485.53 $14,533 - $17,964	37 Added 12.21%	340 $159,000
Q1 2024 May 08, 2024	BUY	$407.69 - $446.08 $42,807 - $46,838	105 Added 53.03%	303 $126,000
Q4 2023 Jan 26, 2024	BUY	$343.0 - $410.68 $62,083 - $74,333	181 Added 1064.71%	198 $80,000
Q2 2023 Aug 04, 2023	SELL	$314.42 - $351.91 $19,179 - $21,466	-61 Reduced 78.21%	17 $5,000
Q1 2023 May 05, 2023	BUY	$283.23 - $323.1 $20,109 - $22,940	71 Added 1014.29%	78 $24,000
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $4,572 - $5,143	-16 Reduced 69.57%	7 $2,000
Q3 2022 Nov 02, 2022	BUY	$273.83 - $305.53 $4,381 - $4,888	16 Added 228.57%	23 $7,000
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $17,701 - $22,345	-100 Reduced 93.46%	7 $2,000
Q2 2021 Aug 09, 2021	SELL	$187.49 - $221.1 $1,124 - $1,326	-6 Reduced 5.31%	107 $21,000
Q1 2021 May 03, 2021	BUY	$207.02 - $241.31 $1,449 - $1,689	7 Added 6.6%	113 $25,000
Q4 2020 Feb 03, 2021	SELL	$207.01 - $276.09 $40,159 - $53,561	-194 Reduced 64.67%	106 $25,000
Q3 2020 Nov 09, 2020	SELL	$255.65 - $303.1 $3,579 - $4,243	-14 Reduced 4.46%	300 $82,000
Q1 2020 May 01, 2020	BUY	$199.77 - $247.81 $2,796 - $3,469	14 Added 4.67%	314 $75,000
Q2 2019 Aug 01, 2019	SELL	$164.61 - $190.37 $4,444 - $5,139	-27 Reduced 8.26%	300 $55,000
Q1 2019 May 06, 2019	BUY	$163.73 - $194.7 $4,420 - $5,256	27 Added 9.0%	327 $60,000
Q2 2018 Aug 03, 2018	SELL	$145.72 - $169.96 $6,703 - $7,818	-46 Reduced 13.29%	300 $51,000
Q1 2018 May 04, 2018	BUY	$151.6 - $177.13 $45,480 - $53,139	300 Added 652.17%	346 $56,000
Q4 2017 Feb 02, 2018	BUY	$137.28 - $155.55 $6,314 - $7,155	46	46 $7,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.

Account

Sandy Spring Bank Vertex Pharmaceuticals Inc Transaction History